# Tacrolimus

## Protopic ointment 0.1% 10gm

| TAH Drug Code      | [EPROT1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EPROT1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Atopic dermatitis (Moderate to Severe), Second-line Short-term & intermittent long-term therapy in the treatment of patients with moderate to severe atopic dermatitis for 16 years old and above.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Dosing             | Atopic dermatitis (Moderate to Severe), Second-line Adolescents (>16 years) active phase, Apply thin layer ointment to affected areas twice daily until signs and symptoms resolve; use minimum amount and rub in gently and completely chronic phase: apply ointment as two times a week to three times a week , re-exame symptoms after 12 months.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Allergic to Tacrolimus, any macrolides, or any other component of Protopic.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Infections and parasites: Local skin infections, whether or not they have a clear cause, include but are not limited to herpetic eczema, folliculitis, herpes simplex, herpes virus infection, Kaposi's varicella-like rash, Eye herpes infection. Metabolic and nutritional diseases: Alcohol intolerance (face flushing or skin irritation after ingesting alcoholic beverages) Nervous system disease: Sensation abnormalities and dullness (hyperesthesia, burning sensation) Skin and subcutaneous tissue diseases: Itching, acne, vinasse, sunburn Systemic diseases and symptoms of the administration site: Administration site burning, administration site itching, administration site warmth, administration site erythema, administration site pain, administration site irritation, administration site paresthesia, administration site rash, administration site edema |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/tacrolimus-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

